Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs-Reference-Cited by-同舟云学术

Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs

Published:2021-08-13 Issue:6 Volume:14 Page:2124-2131
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Connors Brittany¹,Lou Xing‐Jian¹,Subedee Ashim¹,Zhang Kehui¹,Weingarten Michael¹,Narayanan Deepa¹

Affiliation:

1. National Cancer Institute Small Business Innovation Research Development Center Rockville Maryland USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13119

Reference10 articles.

1. An Introduction to the National Institutes of Health SBIR/STTR Programs

2. Engaging SBIR Resources for Development of Surgical Innovations in Oncology

3. Investor Initiatives for NCI SBIR Awardees. National Cancer Institute SBIR Development Center website.https://sbir.cancer.gov/programseducation/investorinitiatives. Accessed July 7 2021.

4. Resources for Investors. National Cancer Institute SBIR Development Centerwebsite.https://sbir.cancer.gov/resources/forinvestors. Accessed July 8 2021.

5. CellSight Technologies.PR Newswire website.https://www.prnewswire.com/news‐releases/cellsight‐technologies‐announces‐strategic‐collaboration‐with‐boehringer‐ingelheim‐to‐develop‐a‐new‐technology‐for‐monitoring‐anti‐tumor‐t‐cell‐activation‐300551203.html. Accessed January 26 2021.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARE program: NCI and FDA interagency collaborations to support oncology small business entrepreneurs;Clinical and Translational Science;2023-01-22